FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099534174> ?p ?o ?g. }

• W3099534174 abstract "Abstract Background Acromegaly is associated with higher morbidity and mortality mainly due to cardiovascular disease. Data on the incidence and evolution of thyroid cancer in acromegaly are controversial. Our objective was to describe the characteristics of a group of acromegalic patients with differentiated thyroid carcinoma (DTC) and analyze their evolution. Methods This is a retrospective multicenter study of 24 acromegalic patients with DTC. The AJCC Staging System 8th Edition was used for TNM staging, and the initial risk of recurrence (RR), initial response and response at the end of follow-up (RFU) were defined according to the 2015 ATA Guidelines. As a control group, 92 patients with DTC without acromegaly were randomly included. Statistical analyses were done using SPSS Statistics 20.0. Results Median age of patients at diagnosis of acromegaly was 49.5 years (range 12–69). The median delay in diagnosis of acromegaly was 3 years (range 0.5–23). Mean baseline IGF-1 level was 2.9 ± 1.1 ULN. Median age at DTC diagnosis was 51.5 years (18–69). At the moment of diagnosis of DTC, 58.3% of the patients had active acromegaly. Median time from DTC diagnosis to acromegaly control was 1.25 years (0.5–7). Mean DTC tumor diameter of the biggest lesion was 14.6 ± 9.2 mm, being multifocal in 37.5%. All tumors were papillary carcinomas, two cases being of an aggressive variety. Lymph node dissection was performed in 8 out of 24 patients and 62.5% had metastases. Only one patient had distant metastases. Radioiodine ablation was given to 87.5% of patients. Nineteen patients (79%) were stage I, four (17%) stage II and one (4%) stage IVb. Initial RR was low in 87% (21/24), intermediate in 9% (2/24) and high in 4% (1/24) patient. RFU was: 83% (19/23) patients with no evidence of disease, 9% (2/23) with indeterminate response, 4% (1/23) with biochemical incomplete response and 4% (1/23) with structural incomplete response, at a median time of FU of 36.5 months. When comparing RFU between acromegalics and controls no statistically significant differences were found. Conclusions Patients with acromegaly and DTC mostly had a low initial RR. When compared with the control group, we found that DTC patients with acromegaly did not have a worse evolution." @default.
• W3099534174 created "2020-11-23" @default.
• W3099534174 creator A5004693958 @default.
• W3099534174 creator A5007165719 @default.
• W3099534174 creator A5015141965 @default.
• W3099534174 creator A5016191048 @default.
• W3099534174 creator A5025053775 @default.
• W3099534174 creator A5025257796 @default.
• W3099534174 creator A5025341777 @default.
• W3099534174 creator A5031736891 @default.
• W3099534174 creator A5032587704 @default.
• W3099534174 creator A5035550645 @default.
• W3099534174 creator A5037619432 @default.
• W3099534174 creator A5038022715 @default.
• W3099534174 creator A5039380632 @default.
• W3099534174 creator A5045121806 @default.
• W3099534174 creator A5054888457 @default.
• W3099534174 creator A5055373420 @default.
• W3099534174 creator A5056938510 @default.
• W3099534174 creator A5059371629 @default.
• W3099534174 creator A5060394908 @default.
• W3099534174 creator A5060595089 @default.
• W3099534174 creator A5063360221 @default.
• W3099534174 creator A5063386256 @default.
• W3099534174 creator A5069039136 @default.
• W3099534174 creator A5078052913 @default.
• W3099534174 date "2020-11-17" @default.
• W3099534174 modified "2023-10-15" @default.
• W3099534174 title "Acromegaly and thyroid cancer: analysis of evolution in a series of patients" @default.
• W3099534174 cites W123434114 @default.
• W3099534174 cites W131449026 @default.
• W3099534174 cites W1842891558 @default.
• W3099534174 cites W1982178657 @default.
• W3099534174 cites W1986145457 @default.
• W3099534174 cites W2002070825 @default.
• W3099534174 cites W2007258249 @default.
• W3099534174 cites W2009717638 @default.
• W3099534174 cites W2010288774 @default.
• W3099534174 cites W2011299983 @default.
• W3099534174 cites W2014729851 @default.
• W3099534174 cites W2020636054 @default.
• W3099534174 cites W2022722603 @default.
• W3099534174 cites W2022874606 @default.
• W3099534174 cites W2051913928 @default.
• W3099534174 cites W2067668440 @default.
• W3099534174 cites W2077878271 @default.
• W3099534174 cites W2088031764 @default.
• W3099534174 cites W2089527908 @default.
• W3099534174 cites W2094031070 @default.
• W3099534174 cites W2099948919 @default.
• W3099534174 cites W2111843196 @default.
• W3099534174 cites W2118341413 @default.
• W3099534174 cites W2126484891 @default.
• W3099534174 cites W2135480490 @default.
• W3099534174 cites W2145150141 @default.
• W3099534174 cites W2153563435 @default.
• W3099534174 cites W2171357500 @default.
• W3099534174 cites W2205918847 @default.
• W3099534174 cites W2238072587 @default.
• W3099534174 cites W2337454626 @default.
• W3099534174 cites W2511071682 @default.
• W3099534174 cites W2517830395 @default.
• W3099534174 cites W2789906464 @default.
• W3099534174 cites W2900697102 @default.
• W3099534174 cites W2950406276 @default.
• W3099534174 cites W4211196325 @default.
• W3099534174 cites W4240093494 @default.
• W3099534174 doi "https://doi.org/10.1186/s40842-020-00113-4" @default.
• W3099534174 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7672811" @default.
• W3099534174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33292786" @default.
• W3099534174 hasPublicationYear "2020" @default.
• W3099534174 type Work @default.
• W3099534174 sameAs 3099534174 @default.
• W3099534174 citedByCount "3" @default.
• W3099534174 countsByYear W30995341742021 @default.
• W3099534174 countsByYear W30995341742022 @default.
• W3099534174 countsByYear W30995341742023 @default.
• W3099534174 crossrefType "journal-article" @default.
• W3099534174 hasAuthorship W3099534174A5004693958 @default.
• W3099534174 hasAuthorship W3099534174A5007165719 @default.
• W3099534174 hasAuthorship W3099534174A5015141965 @default.
• W3099534174 hasAuthorship W3099534174A5016191048 @default.
• W3099534174 hasAuthorship W3099534174A5025053775 @default.
• W3099534174 hasAuthorship W3099534174A5025257796 @default.
• W3099534174 hasAuthorship W3099534174A5025341777 @default.
• W3099534174 hasAuthorship W3099534174A5031736891 @default.
• W3099534174 hasAuthorship W3099534174A5032587704 @default.
• W3099534174 hasAuthorship W3099534174A5035550645 @default.
• W3099534174 hasAuthorship W3099534174A5037619432 @default.
• W3099534174 hasAuthorship W3099534174A5038022715 @default.
• W3099534174 hasAuthorship W3099534174A5039380632 @default.
• W3099534174 hasAuthorship W3099534174A5045121806 @default.
• W3099534174 hasAuthorship W3099534174A5054888457 @default.
• W3099534174 hasAuthorship W3099534174A5055373420 @default.
• W3099534174 hasAuthorship W3099534174A5056938510 @default.
• W3099534174 hasAuthorship W3099534174A5059371629 @default.
• W3099534174 hasAuthorship W3099534174A5060394908 @default.
• W3099534174 hasAuthorship W3099534174A5060595089 @default.
• W3099534174 hasAuthorship W3099534174A5063360221 @default.
• W3099534174 hasAuthorship W3099534174A5063386256 @default.

• next